1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKETS COVERED 15
1.2.2 YEARS CONSIDERED FOR THE STUDY 15
1.3 CURRENCY 16
1.4 LIMITATIONS 16
1.5 STAKEHOLDERS 16

2 RESEARCH METHODOLOGY 17
2.1 RESEARCH APPROACH 17
2.1.1 SECONDARY SOURCES 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY SOURCES 19
2.1.2.1 Key data from primary sources 19
2.2 MARKET SIZE ESTIMATION 20
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22
2.4 RESEARCH ASSUMPTIONS 23

3 EXECUTIVE SUMMARY 24

4 PREMIUM INSIGHTS 29
4.1 URINARY CATHETERS: MARKET OVERVIEW 29
4.2 GEOGRAPHIC ANALYSIS: URINARY CATHETERS MARKET, BY INDICATION (2017) 30
4.3 URINARY CATHETERS MARKET, BY TYPE, 2017–2022 31
4.4 GEOGRAPHICAL SNAPSHOT OF THE URINARY CATHETERS MARKET 31

5 MARKET OVERVIEW 32
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Growing prevalence of urinary incontinence 34
5.2.1.1.1 Increasing rates of obesity 34
5.2.1.1.2 Rapidly increasing geriatric population 35
5.2.1.2 Increasing number of surgical procedures 35
5.2.1.3 Favourable reimbursement scenario 36
5.2.2 RESTRAINTS 36
5.2.2.1 Alternative treatment options for urinary incontinence 36
5.2.3 OPPORTUNITIES 37
5.2.3.1 Emerging Asian countries to offer growth opportunities 37
5.2.4 TRENDS 38
5.2.4.1 Growing preference for single-use catheters and self-catheterization 38

6 URINARY CATHETERS MARKET, BY PRODUCT 39
6.1 INTRODUCTION 40
6.2 INDWELLING CATHETERS 42
6.3 INTERMITTENT CATHETERS 43
6.4 EXTERNAL CATHETERS 44

7 URINARY CATHETERS MARKET BY TYPE 46
7.1 INTRODUCTION 47
7.2 COATED CATHETERS 48
7.3 UNCOATED CATHETERS 49

8 URINARY CATHETERS MARKET, BY GENDER 50
8.1 INTRODUCTION 51
8.2 MALE URINARY CATHETERS 52
8.3 FEMALE URINARY CATHETERS 53

9 URINARY CATHETERS MARKET, BY INDICATION 54
9.1 INTRODUCTION 55
9.2 URINARY INCONTINENCE 56
9.3 GENERAL SURGERY 57
9.4 BENIGN PROSTATIC HYPERPLASIA 58
9.5 SPINAL CORD INJURIES 59

10 URINARY CATHETERS MARKET, BY END USER 60
10.1 INTRODUCTION 61
10.2 HOSPITALS 62
10.3 LONG-TERM CARE FACILITIES 63
10.4 OTHER END USERS 64

11 URINARY CATHETERS MARKET, BY REGION 65
11.1 INTRODUCTION 66
11.2 NORTH AMERICA 68
11.2.1 US 72
11.2.2 CANADA 74
11.3 EUROPE 76
11.3.1 GERMANY 81
11.3.2 UK 82
11.3.3 FRANCE 85
11.3.4 ITALY 87
11.3.5 REST OF EUROPE (ROE) 89
11.4 ASIA 91
11.5 REST OF THE WORLD (ROW) 95

12 COMPETITIVE LANDSCAPE 98
12.1 INTRODUCTION 98
12.2 COMPETITIVE LEADERSHIP MAPPING 98
12.2.1 VISIONARY LEADERS 98
12.2.2 INNOVATORS 98
12.2.3 DYNAMIC DIFFERENTIATORS 98
12.2.4 EMERGING COMPANIES 99
12.3 MARKET SHARE ANALYSIS 100
12.4 COMPETITIVE BENCHMARKING 101
12.4.1 STRENGTH OF PRODUCT PORTFOLIO (FOR ALL 25 PLAYERS) 101
12.4.2 BUSINESS STRATEGY EXCELLENCE (FOR ALL 25 PLAYERS) 102
*Top 25 companies analyzed for this study are B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), C.R. Bard, Inc. (US), Hollister Incorporated (US), Medtronic plc (US), CooK Medical (US), Teleflex Incorporation (US), ConvaTec Group PLC (US), ROCAMED (France), Rochester Medical Corporation (US), Wellspect Healthcare (Denstply IH LTD.) (US), Boston Scientific Corporation (US), Bactiguard (Sweden), Pacific Hospital Supply Co., Ltd. (Taiwan), Amsino International, Inc. (US), Weili Medical Equipment Co., Ltd. (China), Zhanjiang Star Enterprise Co., Ltd. (China), Jinan Chensheng Medical Silicone Rubber Product Co., Ltd. (China), Guangdong Haiou Medical Apparatus Stock Co., Ltd. (China), Guangdong Baihe Medical Technology Co., Ltd. (China), Henan Shuguang Jianshi Medical Equipment Group Co., Ltd (China), Urocare Products, Inc. (US), Degania Silicone Ltd. (Israel), Cure Medical, LLC (US), and Medical Techologies of Georgia (US).

13 COMPANY PROFILES 103
(OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
13.1 B. BRAUN MELSUNGEN AG 103
13.2 BOSTON SCIENTIFIC CORPORATION 106
13.3 COLOPLAST A/S 109
13.4 CONVATEC GROUP PLC 112
13.5 C.R. BARD, INC. 115
13.6 MEDTRONIC PLC 117
13.7 TELEFLEX INCORPORATED 120
13.8 WELLSPECT HEALTHCARE (A SUBSIDIARY OF DENTSPLY IH LTD.) 123
13.9 BACTIGUARD 125
13.10 COOK MEDICAL 127
?
13.11 HOLLISTER INCORPORATED 129
13.12 PACIFIC HOSPITAL SUPPLY CO. LTD 131
13.13 ROCHESTER MEDICAL CORPORATION 133
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

14 APPENDIX 134
14.1 INSIGHTS FROM INDUSTRY EXPERTS 134
14.2 DISCUSSION GUIDE 135
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
14.5 AVAILABLE CUSTOMIZATIONS 140
14.6 RELATED REPORTS 141
14.7 AUTHOR DETAILS 142